Congress and the Federal Reserve have created a massive stock market bubble that risks plunging the world into a complete economic collapse in 2016. At least, that’s the opinion of former Congressman Ron Paul.
“Socialism fails always because you have wage and price controls,” the three-time presidential candidate explained to Newsmax on Tuesday. “But we in the West have control of the economy and economic planning .
According to Morgan Stanley (NYSE:MS), Tesla Motors, Inc.’s (NASDAQ:TSLA) stock price has serious upside potential. Adam Jonas, analyst at Morgan Stanley, raised his price target for Tesla from $280.00 to $465.00, which is 91.2% higher than Friday’s closing price of $243.15. (Source:Bloomberg, August 17, 2015.)
Tesla’s shares opened more than five percent higher on Monday morning, before settling down to a 4.44% gain at .
Despite a few years of weak gold prices, China’s currency depreciation could be the tipping point that drives gold above $5,000. The yellow metal skyrocketed between 2001 and 2011, and another decade of similar growth is not unfeasible.
Let me explain.
A series of events in China have me convinced that gold prices are set to explode. The yellow metal has lost more than 40% since peaking near $1,900 in .
Despite stagnating prices in recent years, gold is set to explode as pessimism sets into the market. Excessive printing by the Federal Reserve has embedded fragility into financial markets, building a house of cards that will buckle under the pressure of an interest rate hike. The resulting stock market crash will send investors running back to safe haven assets. Since 2008, the Fed has engaged in a range of “easy .
The U.S. stock markets have experienced two strong years of back-to-back gains; the S&P 500 soared approximately 30% in 2013 and a solid 13% in 2014; and the Dow Jones Industrial Average recently topped 18,000 for the first time ever. With the Federal Reserve expected to barely increase interest rates in the second half of 2015, the stock market looks to be the investment of choice for income-starved investors this .
SpaceX IPO the Final Frontier?
Is an initial public offering (IPO) the final frontier for SpaceX? Investors might be interested in gravitating toward a SpaceX IPO, but the company doesn’t seem to be in any rush to jettison private life.
SpaceX, a sort of private NASA, was founded in 2002 by Elon Musk. No one-hit wonder, Musk is also famous for starting successful firms like PayPal and Tesla Motors, .
Global Blood Therapeutics is going public on Wednesday August 12th. Here’s what investors need to know about its initial public offering (IPO). (Source: The Securities and Exchange Commission, July 31, 2015.)
Who is Global Blood Therapeutics?
Global Blood Therapeutics is a biopharmaceutical company committed to developing treatments for blood-based disorders. The company is currently focusing on the development of its initial product candidate, GBT440, a once-daily oral prophylactic therapy for .
In preparation for its initial public offering (IPO), the Australian-based Benitec Biopharma Ltd (NASDAQ:BNTC) revealed a price target and expected launch date of the week of August 3, 2015. Here’s what investors need to know about the upcoming Benitec Biopharma IPO.
Who is Benitec?
Benitec is a clinical-stage biotechnology firm that has a proprietary therapeutic technology platform in development which combines gene silencing and gene therapy with the goal of .
GC Aesthetics plc (NASDAQ:GCAA) has submitted an F-1 filling to the Securities and Exchange Commission (SEC) on June 24, 2015, for its initial public offering (IPO). The shares are expected to hit the market this week. Here’s what investors need to know about the upcoming GC Aesthetics IPO. (Source: SEC, last accessed August 5, 2015.)
Who is GC Aesthetics?
GC Aesthetics is a Dublin-based cosmetic and aesthetics product company. GC .
Aimmune Therapeutics, Inc. (NASDAQ:AIMT) shares are ready to hit the public trading market this week. The pharmaceutical company submitted S-1 filling to the Securities and Exchange Commission (SEC) on July 6, 2015 for its initial public offering (IPO). Here’s what investors need to know about the upcoming Aimmune IPO. (Source: SEC, last accessed August 5, 2015.)
Who is Aimmune?
Aimmune is a research-based company who intends to protect people that .
Immediate term outlook:
The bear market rally in stocks that started in March 2009, extended because of unprecedented central bank money printing, is coming to an end. Gold bullion is up $1,000 an ounce since we first recommended it in 2002 and we are still bullish on the physical metal.
Short-to-medium term outlook:
World economies are entering their slowest growth period since 2009. The Chinese economy grew last year at its slowest pace in 24 years. Japan is in recession. The eurozone is in depression. With almost half the S&P 500 companies deriving revenue outside the U.S., slower world economic growth will negatively impact revenue and earnings growth of American companies. Domestically, America’s gross domestic product grew by only a meager 2.3% in the second quarter, which will negatively impact an already overpriced equity market.
Estimates Aug. 27, 2015
Trailing 12-month EPS for Dow Jones companies (Most Recent Quarter)